Overview
Pulmonary emphysema is a chronic obstructive pulmonary disease characterized by abnormal permanent enlargement of air spaces distal to the terminal bronchioles, leading to impaired gas exchange and airflow obstruction. 9Diagnosis
Clinical Presentation: Chronic shortness of breath, chronic cough, and decreased exercise tolerance.
Diagnostic Tests:
- Chest X-ray: May show hyperinflation and flattened diaphragms.
- Pulmonary Function Tests (PFTs): Reduced FEV1/FVC ratio and decreased DLCO indicative of airflow obstruction and gas trapping. 9
- High-Resolution CT (HRCT): Characteristic findings include destruction of alveolar walls and bullae formation.
Grading: Severity often assessed using Global Initiative for Chronic Obstructive Lung Disease (GOLD) staging based on symptoms and spirometry results. 9Management
First-Line Treatments:
- Bronchodilators: Short-acting (e.g., albuterol) and long-acting (e.g., tiotropium) for symptom relief.
- Inhaled Corticosteroids: Used in combination with long-acting bronchodilators in moderate to severe cases to reduce exacerbations. 9
Adjunctive Treatments:
- Oxygen Therapy: To maintain adequate oxygen saturation.
- Pulmonary Rehabilitation: Improves exercise capacity and quality of life.
- Vaccinations: Annual influenza and pneumococcal vaccines to prevent exacerbations. 9Special Populations
Pregnancy: Limited data; management focuses on symptom control and monitoring maternal and fetal well-being. 8
Pediatrics: Rare; management involves addressing underlying causes and supportive care. 7
Elderly: Increased risk of complications; tailored management with emphasis on symptom relief and prevention of exacerbations. 6
Comorbidities: Patients with comorbidities like coronary artery disease may experience paradoxical bradycardia during hypoxemia; close monitoring is essential. 3Key Recommendations
Use pulmonary function tests for diagnosis and monitoring disease progression (Evidence: Moderate) 9
Implement bronchodilators as first-line therapy, tailored to severity (Evidence: Moderate) 9
Consider inhaled corticosteroids in combination with long-acting bronchodilators for patients with frequent exacerbations (Evidence: Moderate) 9
Regular vaccinations against influenza and pneumococcus are recommended to reduce exacerbation frequency (Evidence: Moderate) 9
Monitor and manage potential complications, especially in high-risk groups like the elderly or those with comorbidities (Evidence: Expert opinion) 63References
1 Lo SJ, Hughes J, Armstrong A. Non-infective subcutaneous emphysema of the hand secondary to a minor webspace injury. Journal of hand surgery (Edinburgh, Scotland) 2005. link
2 Rettwitz-Volk W, Schlösser R, von Loewenich V. One-sided high-frequency oscillating ventilation in the treatment of neonatal unilateral pulmonary emphysema. Acta paediatrica (Oslo, Norway : 1992) 1993. link
3 Kobayashi S, Yoshida K, Nishimura M, Miyamoto K, Kawakami Y. Paradoxical bradycardia during exercise and hypoxic exposure. The possible direct effect of hypoxia on sinoatrial node activity in humans. Chest 1992. link
4 Linnabary RD, Tarrier MP. Acute bovine pulmonary emphysema caused by the fungus Fusarium semitectum. Veterinary and human toxicology 1988. link
5 Yoganathan S. Mediastinal emphysema following extradural analgesia in a ventilated patient. Journal of the Royal Army Medical Corps 1988. link
6 Manzari JA. Near fatal complication secondary to a poorly designed tracheostomy connector. Chest 1984. link
7 Tarján E, Tolnay P, Appel J, Petó L, Dienes Z. Experimental pulmonary emphysema: its induction in rats by leuko-elastase extracted from purulent sputum. Acta medica Academiae Scientiarum Hungaricae 1980. link
8 Brandfass RT, Martinez DM. Mediastinal and subcutaneous emphysema in labor. Southern medical journal 1976. link
9 Broks PD. Radiological features of pulmonary venous hypertension in pulmonary emphysema. Radiologia clinica 1975. link
10 Forgacs J, Carll WT. Mycotoxicosis: toxic fungi in tobaccos. Science (New York, N.Y.) 1966. link